These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An immunodominant site of acetylcholine receptor in experimental myasthenia mapped with T lymphocyte clones and synthetic peptides. Pachner AR; Kantor FS; Mulac-Jericevic B; Atassi MZ Immunol Lett; 1989 Feb; 20(3):199-204. PubMed ID: 2469649 [TBL] [Abstract][Full Text] [Related]
3. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis. Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306 [TBL] [Abstract][Full Text] [Related]
4. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor. Shenoy M; Oshima M; Atassi MZ; Christadoss P Clin Immunol Immunopathol; 1993 Mar; 66(3):230-8. PubMed ID: 7679342 [TBL] [Abstract][Full Text] [Related]
5. The T-cell repertoire in myasthenia gravis involves multiple cholinergic receptor epitopes. Link H; Xu ZY; Melms A; Kalbacher H; Sun JB; Wang ZY; Fredrikson S; Olsson T Scand J Immunol; 1992 Sep; 36(3):405-14. PubMed ID: 1381518 [TBL] [Abstract][Full Text] [Related]
6. T-cell antigenic sites involved in myasthenia gravis: correlations with antibody titre and disease severity. Berrih-Aknin S; Cohen-Kaminsky S; Lepage V; Neumann D; Bach JF; Fuchs S J Autoimmun; 1991 Feb; 4(1):137-53. PubMed ID: 2031657 [TBL] [Abstract][Full Text] [Related]
7. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. Matsuo H; Batocchi AP; Hawke S; Nicolle M; Jacobson L; Vincent A; Newsom-Davis J; Willcox N J Immunol; 1995 Oct; 155(7):3683-92. PubMed ID: 7561069 [TBL] [Abstract][Full Text] [Related]
8. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides. Fujii Y; Lindstrom J J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133 [TBL] [Abstract][Full Text] [Related]
9. A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. Harcourt GC; Sommer N; Rothbard J; Willcox HN; Newsom-Davis J J Clin Invest; 1988 Oct; 82(4):1295-300. PubMed ID: 2459161 [TBL] [Abstract][Full Text] [Related]
10. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides. Atassi MZ; Oshima M Crit Rev Immunol; 1997; 17(5-6):481-95. PubMed ID: 9419435 [TBL] [Abstract][Full Text] [Related]
11. Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene. Melms A; Chrestel S; Schalke BC; Wekerle H; Mauron A; Ballivet M; Barkas T J Clin Invest; 1989 Mar; 83(3):785-90. PubMed ID: 2466050 [TBL] [Abstract][Full Text] [Related]
12. Immuno-suppressive peptides for a human T cell clone autoreactive to a unique acetylcholine receptor alpha subunit peptide presented by the disease-susceptible HLA-DQ6 in infant-onset myasthenia gravis. Kanai T; Nomura Y; Segawa M; Takagi K; Senju S; Matsushita S; Nishimura Y Hum Immunol; 1997; 56(1-2):28-38. PubMed ID: 9455491 [TBL] [Abstract][Full Text] [Related]
13. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes. Infante AJ; Thompson PA; Krolick KA; Wall KA J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927 [TBL] [Abstract][Full Text] [Related]
14. Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Sommer N; Harcourt GC; Willcox N; Beeson D; Newsom-Davis J Neurology; 1991 Aug; 41(8):1270-6. PubMed ID: 1714058 [TBL] [Abstract][Full Text] [Related]
15. T cell responses to human recombinant acetylcholine receptor-alpha subunit in myasthenia gravis and controls. Sun JB; Harcourt G; Wang ZY; Hawke S; Olsson T; Fredrikson S; Link H Eur J Immunol; 1992 Jun; 22(6):1553-9. PubMed ID: 1376263 [TBL] [Abstract][Full Text] [Related]
16. Immunological heterogeneity of autoreactive T lymphocytes against the nicotinic acetylcholine receptor in myasthenic patients. Zhang Y; Schluep M; Frutiger S; Hughes GJ; Jeannet M; Steck A; Barkas T Eur J Immunol; 1990 Dec; 20(12):2577-83. PubMed ID: 2269325 [TBL] [Abstract][Full Text] [Related]
17. T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo californica). Zhang Y; Barkas T; Juillerat M; Schwendimann B; Wekerle H Eur J Immunol; 1988 Apr; 18(4):551-7. PubMed ID: 2452743 [TBL] [Abstract][Full Text] [Related]
18. T cell responses in EAMG-susceptible and non-susceptible mouse strains after immunization with overlapping peptides encompassing the extracellular part of Torpedo californica acetylcholine receptor alpha chain. Implication to role in myasthenia gravis of autoimmune T-cell responses against receptor degradation products. Oshima M; Yokoi T; Deitiker P; Atassi MZ Autoimmunity; 1998; 27(2):79-90. PubMed ID: 9583739 [TBL] [Abstract][Full Text] [Related]
19. Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera. Loutrari H; Tzartos SJ; Claudio T Eur J Immunol; 1992 Nov; 22(11):2949-56. PubMed ID: 1385157 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of T cell proliferation specific for acetylcholine receptor epitopes related to myasthenia gravis with antibody to T cell receptor or with competitive synthetic polymers. Brocke S; Dayan M; Steinman L; Rothbard J; Mozes E Int Immunol; 1990; 2(8):735-42. PubMed ID: 1707306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]